Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) Director Jack R. Lazar sold 2,000 shares of Astera Labs stock in a transaction on Friday, October 11th. The shares were sold at an average price of $69.95, for a total value of $139,900.00. Following the transaction, the director now owns 135,000 shares in the company, valued at $9,443,250. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Astera Labs Stock Up 5.0 %
Astera Labs stock opened at $65.59 on Thursday. Astera Labs, Inc. has a 12 month low of $36.22 and a 12 month high of $95.21. The business has a 50 day moving average price of $47.25 and a two-hundred day moving average price of $58.11.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.13 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.02. The business had revenue of $76.90 million for the quarter, compared to the consensus estimate of $72.41 million. The firm’s revenue for the quarter was up 17.8% on a year-over-year basis. Equities research analysts forecast that Astera Labs, Inc. will post -0.54 EPS for the current year.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on the company. Evercore ISI lowered their target price on Astera Labs from $98.00 to $80.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 7th. Needham & Company LLC restated a “buy” rating and set a $65.00 price target on shares of Astera Labs in a report on Wednesday, October 9th. Roth Mkm dropped their price objective on shares of Astera Labs from $85.00 to $60.00 and set a “buy” rating on the stock in a research note on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft dropped their target price on Astera Labs from $85.00 to $60.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Finally, Barclays reduced their price target on Astera Labs from $85.00 to $70.00 and set an “overweight” rating for the company in a report on Wednesday, August 7th. Eleven investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $73.09.
Check Out Our Latest Analysis on Astera Labs
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Further Reading
- Five stocks we like better than Astera Labs
- How to Invest in Small Cap StocksÂ
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- How to Find Undervalued Stocks
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- What is a SEC Filing?
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.